ESR1 and cancer: CDK9-mediated overexpression of c-MYC is associated with estrogen receptor (ER) independent growth in breast cancers resistant to endocrine therapy.379 High c-MYC and CDK9 levels correlate with multiple endocrine therapy-resistant MCF7 cancer cell lines.